West Pharmaceutical Services, Inc.WSTNYSE
Loading
Cost of Revenue Over TimeStrong
Percentile Rank100
3Y CAGR+4.1%
5Y CAGR+7.4%
Year-over-Year Change
Direct costs attributable to producing goods sold
3Y CAGR
+4.1%/yr
vs +10.5%/yr prior
5Y CAGR
+7.4%/yr
Recent deceleration
Acceleration
-6.4pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
1.4x
Solid growth
Streak
9 yr
Consecutive growthStrong
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $1.97B | +4.2% |
| 2024 | $1.89B | +4.0% |
| 2023 | $1.82B | +4.1% |
| 2022 | $1.75B | +5.4% |
| 2021 | $1.66B | +20.2% |
| 2020 | $1.38B | +11.7% |
| 2019 | $1.23B | +5.4% |
| 2018 | $1.17B | +8.0% |
| 2017 | $1.09B | +7.7% |
| 2016 | $1.01B | - |